LFG
TAK icon

Larson Financial Group’s Takeda Pharmaceutical TAK Stock Holding History

Larson Financial Group’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$121K Sell
7,531
-228
-3% -$3.77K ﹤0.01% 1080
2026
Q1 		$144K Buy
7,759
+759
+11% +$13.3K ﹤0.01% 833
2025
Q4 		$109K Sell
7,000
-823
-11% -$11.8K ﹤0.01% 906
2025
Q3 		$115K Buy
7,823
+2,379
+44% +$35.3K ﹤0.01% 861
2025
Q2 		$84.2K Sell
5,444
-24
-0.4% -$355 ﹤0.01% 905
2025
Q1 		$81.3K Buy
5,468
+496
+10% +$6.95K ﹤0.01% 855
2024
Q4 		$65.8K Hold
4,972
– – ﹤0.01% 824
2024
Q3 		$70.7K Buy
4,972
+485
+11% +$6.88K ﹤0.01% 810
2024
Q2 		$58.1K Hold
4,487
– – ﹤0.01% 776
2024
Q1 		$62.3K Sell
4,487
-3,675
-45% -$53.4K ﹤0.01% 640
2023
Q4 		$116K Buy
+8,162
New +$116K 0.01% 461
2022
Q2 		– Sell
-410
Closed -$6K – 1294
2022
Q1 		$6K Hold
410
– – ﹤0.01% 774
2021
Q4 		$6K Buy
410
+10
+3% +$140 ﹤0.01% 786
2021
Q3 		$7K Hold
400
– – ﹤0.01% 653
2021
Q2 		$7K Buy
+400
New +$6.81K ﹤0.01% 612
2019
Q4 		– Sell
-70
Closed -$1K – 660
2019
Q3 		$1K Buy
+70
New +$1.21K ﹤0.01% 516

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Larson Financial Group's TAK Position: Q2 2026 in Review

Larson Financial Group reduced its Takeda Pharmaceutical (TAK) stake by 2.9% in Q2 2026, selling an estimated $3.77K and leaving 7,531 shares worth $121K. The position accounts for ﹤0.01% of the portfolio, ranked #1080.

Larson Financial Group first reported a position in TAK in Q3 2019 and has held it in 16 quarters since. The position peaked at $144K in Q1 2026. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Larson Financial Group held 7,531 shares of Takeda Pharmaceutical worth $121K as of Q2 2026.
  • Larson Financial Group sold 228 Takeda Pharmaceutical shares in Q2 2026, an estimated $3.77K.
  • Takeda Pharmaceutical made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #1080 holding.
  • Larson Financial Group first reported a position in Takeda Pharmaceutical in Q3 2019 and has held it in 16 quarters since.
  • Larson Financial Group's Takeda Pharmaceutical position peaked at $144K in Q1 2026.
  • 376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.